drugset / Trial / NCT02100644

Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study

NCT02100644

Phase 4 Completed 33 enrolled GlaxoSmithKline
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to examine whether the VPA (Valproate) dose can be reduced by additional administration of LTG (Lamotrigine) in Japanese pre-menopausal female epilepsy patients aged 15 years or older, whose seizures are well controlled by VPA monotherapy.

Timeline

Start
2014-04-12
Primary completion
2015-05-11
Completion
2015-05-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule Oral

Indications